News Releases

August 7, 2017

This comprehensive guide to the methods for preparing budget-impact analyses that adhere to published guidelines is a must have for the builder and budget holder.
The first of its kind for budget-impact analysis,

July 20, 2017

As part of a post-approval safety commitment to the U.S.

July 6, 2017

Research conducted to test the real-world feasibility and value of the BEDS-7 screening tool has recently been published in The Primary Care Companion for CNS Disorders.

June 26, 2017

RTI Health Solutions is pleased to announce that Ken Rothman, DrPH, Distinguished Fellow and Vice President for Epidemiology Research, has been awarded the Career Accomplishment Award by the Society for Epidemiologic Research (SER). Rothman received a plaque to commemorate the award on June 22nd...

June 23, 2017

RTI Health Solutions is honored to have staff that are leaders in research and academia. Our researchers often serve on industry advisory boards and teach at universities and industry sponsored courses.   Dr. Susana Perez-Gutthann, Vice President and Global Head of Epidemiology, recently...

June 19, 2017

Research currently relies mostly on pregnancy exposure registries to gather data for safety studies once drugs are on the market. RTI Health Solutions researchers believe that, for many of those studies, there is a better way to collect that data.

June 15, 2017

Nepafenac is a non-steroidal anti-inflammatory drug approved to treat pain and inflammation in the first 2 weeks following cataract surgery in adults. In 2016, a new indication for this drug was approved – prevention of postoperative macular edema in patients with diabetes for use up to 60 days...

June 7, 2017

RTI Health Solutions’ James Kaye has just returned from a very busy American Society of Clinical Oncology (ASCO) Annual Meeting. He shares these insights from that meeting.

May 26, 2017

To celebrate an ongoing commitment to high-quality, reliable research, several RTI International and RTI Health Solutions researchers were recognized May 16, 2017, for their published contributions at an RTI sponsored Authors’ Awards dinner. 

May 23, 2017

At a recent workshop convened by the Duke-Margolis Center for Health Policy, Dana DiBenedetti, PhD, Executive Director of Patient-Centered Outcomes Assessment at RTI Health Solutions presented information concerning the use of interviews conducted as part of clinical trials as an emerging method...

May 19, 2017

On World IBD Day, RTI Health Solutions joins with organizations and individuals around the world to support those living with irritable bowel disease (IBD). RTI Health Solutions is committed to providing trusted research to aid the development of treatments. 

May 8, 2017

When our cholesterol levels are where they should be, it’s good for our heart. When cholesterol levels are elevated, it increases the risk for coronary heart disease (CHD). The first line of defense is usually a change in diet. If that alone does not bring cholesterol levels to where they should...

May 3, 2017

Chronic obstructive pulmonary disease (COPD), a chronic lung disease, is debilitating and makes breathing difficult for those affected by it. Its impact on quality of life and health care costs is substantial.

April 27, 2017

Childhood asthma is a significant public health problem. Caregivers must identify and manage diverse environmental triggers and promote appropriate use of preventive asthma medications. 

April 21, 2017

In a time of rapidly transforming communication technologies, developers and researchers are creating new ways to track and combat disease. A new book presents an integrated look at the methods that are shaping the use of communication technology in health care.

April 10, 2017

As the number of treatments available for relapsing multiple sclerosis (RMS) grows, evaluating patient treatment preferences can help in understanding the potential value of treatments.

March 13, 2017

RTI has been recognized by the Ethisphere Institute, a global leader in defining and advancing the standards of ethical business practices, as a 2017 World’s Most Ethical Company®

March 7, 2017

Improving Outcomes for Noncommunicable Diseases in Low- and Middle-Income Countries is a compilation of RTI International and RTI Health Solutions’ work with developing countries to find solutions for growing health threats that affect their well-being and economies. This book presents the...

February 28, 2017

The theme for Rare Disease Day 2017 is research. RTI Health Solutions is proud to be part of the community conducting research to support patients with rare diseases.

February 24, 2017

WorldatWork, a nonprofit human resources (HR) association and compensation authority, awarded RTI International the WorldatWork’s Seal of Distinction for 2017. RTI Health Solutions is a business unit of RTI International. The seal is a unique mark of excellence designed to identify...

February 24, 2017

Patient-reported outcomes (PRO) data is becoming increasingly important in randomized controlled trials. Without complete and transparent reporting, though, readers may have difficulty understanding the methodology used and interpreting trial results. The result is an unfortunate waste of...

February 20, 2017

Cilostazol is a blood clotting inhibitor drug approved in Europe in 2002. It is used to alleviate painful leg cramps during exercise caused by a lack of blood flow. In 2013, the European Medicines Agency recommended labeling changes and requested a drug utilization study to evaluate the impact...

February 15, 2017

The study Assessing the Burden of Treatment-emergent Adverse Events Associated with Atypical Medications, published in BMC Psychiatry, qualitatively assessed the occurrence and burden of side effects from these drugs from both patients’ and physician’s perspectives.

February 13, 2017

Researchers from RTI Health Solutions have published a systematic review in PharmacoEconomics that identified published economic analyses of new oral anticoagulants used to prevent venous thromboembolism after knee and hip replacement. The researchers summarized the modeling techniques employed...

January 26, 2017

Payers worldwide recognize the value of patient reported outcomes (PRO) data in decision making. But what are the characteristics of data that most strongly influence payer decision making? And what impact does that data have on reimbursement decisions and market access?